@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_head { this: np:hasAssertion dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_assertion; np:hasProvenance dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_provenance; np:hasPublicationInfo dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_publicationInfo; a np:Nanopublication . dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_assertion a np:Assertion . dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_provenance a np:Provenance . dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_publicationInfo a np:PublicationInfo . } dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_assertion { miriam-gene:64754 a ncit:C16612 . lld:C1458155 a ncit:C7057 . dgn-gda:DGN967ed3380a67e4f28d7a5125acafcc3d sio:SIO_000628 miriam-gene:64754, lld:C1458155; a sio:SIO_001121 . } dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_provenance { dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_assertion dcterms:description "[Differences in expression profiles were also found to exist between individual breast tumors and, in some cases, were significantly associated with conventional pathological parameters and prognostic indices: tumor grade (K (lysine) acetyltransferase 5 (KAT5), HDAC1, KDM4A, SUV39H1 and KDM6A)); TNM stage (SUV39H1, K (lysine) acetyltransferase 2B (KAT2B), lysine (K)-specific demethylase 1A (KDM1A), KDM4A, lysine (K)-specific demethylase 5C (KDM5C), K (lysine) acetyltransferase 8 (KAT8), HDAC5 and KAT5)); Nottingham Prognostic Index (KDM5C, myeloid/lymphoid or mixed-lineage leukemia (MLL), KAT8 and SET and MYND domain containing 3 (SMYD3)); receptor status (KAT5, SMYD3 and KDM1A); histological type (KAT5, KDM5C, KAT8, KDM4A and MLL); disease-free survival (SUV39H1, SMYD3, HDAC5, KDM6A, HDAC1, KDM1A, KDM4A, KAT8, KDM5C, KAT5 and MLL) and overall survival (KAT8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:22199269; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP939856.RAm-JHb2OQI2yOtDZKet1Lv4MqNFExqhUGMQKumdkqPvI130_publicationInfo { this: dcterms:created "2015-08-25T14:47:14+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }